Cell-matrix interactions in aging: Role of receptors and matricryptins

Ageing Research Reviews

Volumn 3, Issue 2, 2004, Pages 233-247

  Labat Robert, J ^a  

^a HÔTEL DIEU   (France)

Author keywords

Aging; Cryptic sites; Elastin; Fibronectin; Integrins; Matricryptins

Indexed keywords

COLLAGENASE 3; ELASTIN; FIBRONECTIN; FIBRONECTIN RECEPTOR; FREE RADICAL; INTEGRIN; INTEGRIN RECEPTOR; INTERSTITIAL COLLAGENASE; LAMININ RECEPTOR; MATRICRYPTIN; MATRIX METALLOPROTEINASE; MATRIX PROTEIN; PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

AGING; CUTANEOUS PARAMETERS; ENZYME DEGRADATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; GLYCATION; HOMEOSTASIS; HUMAN; INFLAMMATORY DISEASE; MACROMOLECULE; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TUMOR GROWTH;

EID: 1242270673     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2003.10.002     Document Type: Review

References (87)

1. Aguirre K.M., McCormick R.J., Schwarzbauer J.E. Fibronectin self-association is mediated by complementary sites within the amino-terminal one-third of the molecule. J. Biol. Chem. 269:1994;27863-27868.
2. Baneyx, G., Baugh, L., Vogel, V., 2002. Supramolecular chemistry and self-assembly special feature: fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc. Natl. Acad. Sci. USA 99, 5139-5143.
3. Benazzoug Y., Borchiellini C., Labat-Robert J., Robert L., Kern P. Effect of high-glucose concentrations on the expression of collagens and fibronectin by fibroblasts in culture. Exp. Gerontol. 33:1998;445-455.
4. Bizbiz, L., Alperovitch, A., Robert, L., and the EVA Group, 1997. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhiitors in relation with cardiovascular risk factor. The EVA Study. Atherosclerosis 131, 73-78.
5. Bizbiz, L., Labat-Robert, J., Alperovitch, A., Robert, L., and the EVA Group, 1997. Cardiovascular determinants of plasma fibronectin in an elderly population. The EVA Study. Arch. Gerontol. Geriatrics. 25, 201-209.
6. Bizot-Foulon V., Bouchard B., Hornebeck W., Dubertret L., Bertaux B. Uncoordinated expressions of type I and III collagens, collagenase and tissue inhibitor of matrix metalloproteinase 1 along in vitro proliferative life span of human skin fibroblasts. Cell Biol. Int. 19:1995;129-135.
7. Bosset S., Barre P., Chalon A., Lazou K., Kurfurst R., Bonte F., Schnebert S., Disant F., Le Varlet B., Nicolas J.F. Decreased expression of keratinocyte beta1 integrins in chronically sun-exposed skin in vivo. Br. J. Dermatol. 148:2003;770-778.
8. Bouissou, H., Pieraggi, M.T., Julian, M., 1985. Aging of elastic tissue in skin and arteries. In: Robert, L., Murata, K., Nagai, Y. (Eds.), Degenerative Diseases of Connective Tissue and Aging. Kodansha, Tokyo, pp. 203-216.
9. Boyer B., Kern P., Fourtanier A., Labat-Robert J. Age-dependent variations of the biosyntheses of fibronectin and fibrous collagens in mouse skin. Exp. Gerontol. 26:1991;375-382.
10. Boyer, B., Fourtanier, A., Kern, P., Labat-Robert, J., 1992. J. Photochem. Photobiol. B 14, 247-259.
11. Bucala R., Cerami A. Advanced glycosylation. Chemistry, biology and implications for diabetes and aging. Adv. Pharmacol. 23:1992;1-34.
12. Bultmann H., Santas A.J., Mesciotta Paters D.M. Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin. J. Biol. Chem. 273:1998;2601-2609.
13. Burgess M.L., McCrea J.C., Hedrick H.L. Age-associated changes in cardiac matrix and integrins. Mech. Ageing. Dev. 122:2001;1739-1756.
14. Burke E.M., Horton W.E., Pearson J.D., Crow M.T., Martin G.R. Altered transcriptional regulation of human interstitial collagenase in cultured skin fibroblasts from older donors. Exp. Gerontol. 29:1994;37-53.
15. Chandrasekhar S., Millis A.J.T. Fibronectin from aged fibroblasts is defective in promoting cell adhesion. J. Cell. Physiol. 103:1980;47-54.
16. Chandrasekhar S., Sorrentino J.A., Millis A.J. Interaction of fibronectin with collagen: age-specific defect in the biological activity of human fibroblast fibronectin. Proc. Natl. Acad. Sci. USA. 80:1983;4747-47751.
17. Chang C., Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell. Biol. 11:2001;537-543.
18. Charonis A.S., Reger L.A., Dege J.E., Kouzi-Koliakos K., Furcht L.T., Wohlhuetter R.M., Tsilibary E.C. Laminin alterations after in vitro nonenzymatic glucosylation. Diabetes. 39:1990;807-814.
19. Christopher R.A., Judge S.R., Vincent P.A., Higgins P.J., McLeown-Longo P.J. The amino-terminal matrix assembly domain of fibronectin stabilizes cell shape and prevents cell cycle progression. J. Cell. Sci. 112:1999;3225-3235.
20. Davis G.E., Bayless K.J., Davis M.J., Meininger G.A. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am. J. Pathol. 156:2000;1489-1499.
21. DePetro G., Barlati S., Vartio T., Vaheri A. Transformation-enhancing activity of gelatin-binding fragments of fibronectin. Proc. Natl. Acad. Sci. USA. 78:1981;4965-4969.
22. Emod I., Lafaye P., Planchenault T., Lambert-Vidmar S., Imhoff J.M., Keil-Dlouha V. Potential proteolytic activity of fibronectin: fibronectin laminase and its substrate specificity. Biol. Chem. Hoppe-Seyler. 371:1990;129-135.
23. Faury G., Ristori M.T., Verdetti J., Robert L. Effect of elastin peptides on vascular tone. J. Vasc. Res. 32:1995;112-119.
24. Faury G., Chabaud A., Ristori M.T., Robert L., Verdetti J. Effect of age on the vasodilatory action of elastin peptides. Mech. Ageing Dev. 95:1997;31-42.
25. Flickinger K.S., Carter W.G., Culp L.A. Deficiency in integrin-mediated transmembrane signaling and microfilament stress fiber formation by aging fibroblasts from normal and Down's syndrome patients. Exp. Cell. Res. 203:1992;466-475.
26. Fukai F., Takahashi H., Habu Y., Kubushiro N., Katayama T. Fibronectin harbors anticell adhesive activity. Biochem. Biophys. Res. Commun. 220:1996;394-398.
27. Fülöp T., Wei S.M., Robert L., Jacob M.P. Determination of elastin peptides in normal and arteriosclerotic human sera by ELISA. Clin. Physiol. Biochem. 8:1990;273-282.
28. Fülöp T., Jacob M.P., Khalil A., Wallach J., Robert L. Biological effects of elastin peptides. Pathol. Biol. 46:1998;497-506.
29. Halliday N.L., Tomasek J.J. Mechanical properties of the extracellular matrix influence fibronectin fibril assembly in vitro. Exp. Cell. Res. 217:1995;109-117.
30. Hocking D.C., Kowalski K. A cryptic fragment from fibronectin's III1 module localizes to lipid rafts and stimulates cell growth and contractility. J. Cell. Biol. 158:2002;175-184.
31. Holzenberger M., Leviinzi S.A., Herzog C.P., Deak S.B., Robert L., Boyd C.D. Quantitation of tropoelastin messenger RNA and assessment of alternative splicing in human skin fibroblasts by reverse transcriptase polymerase chain reaction. PCR-Meth. Appl. 3:1993;107-114.
32. Homandberg G.A., Williams J.E., Grant D., Schumacher B., Eisenstein R. Heparin-binding fragments are potent inhibitors of endothelial cell growth. Am. J. Pathol. 120:1985;327-332.
33. Homandberg G.A., Hui F., Wen C. Fibronectin fragments mediated cartilage chondrolysis. I. Suppression by antioxidants. Biochim. Biophys. Acta. 1317:1996;134-142.
34. Homandberg G.A., Wen C., Hui G. Cartilage damaging activity of fibronectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage. 6:1998;231-244.
35. Hornebeck W. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol. Biol. 51:2003;569-573.
36. Hornebeck, W., Robert, L., 1986. Interactions between elastic fibers and cells. In: Labat-Robert, J., Timpl, R., Robert, L. (Eds.), Structural Glycoproteins in Cell-Matrix Interactions. Karger, Basel, pp. 58-77.
37. Hu Q., Moerman E.J., Goldstein S. Altered expression and regulation of the alpha5beta1 integrin-fibronectin receptor lead to reduced amounts of functional alpha5beta1 heterodimer on the plasma membrane of senescent human diploid fibroblasts. Exp. Cell. Res. 224:1996;251-263.
38. Huhtala P., Humphries M.J., McCarthy J.B., Tremble P.M., Werb Y., Damsky C.H. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell. Biol. 129:1995;867-879.
39. Huynh Q.N., Wang S., Tafolla E., Gansky D.A., Kapila S., Annitage G.C.et al. Specific fibronectin fragments are markers of periodontal disease status. J. Periodontol. 73:2002;1101-1110.
40. Hynes R.O. Integrins: a family of cell surface receptors. Cell. 48:1987;549-554.
41. Hynes, R.O., 1990. Fibronectins. Springer-Verlag, Berlin.
42. Hynes R.O. The dynamic dialogue between cells and matrices: implications of fibronectin's elasticity. Proc. Natl. Acad. Sci. USA. 96:1999;2588-2590.
43. Kähäri V.M., Saarialho-Kere U. Matrix metalloproteinases in skin. Exp. Dermatol. 6:1997;199-213.
44. Kapila Y.L., Kapila S., Johnson P.W. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol. 15:1996;251-261.
45. Kern P., Asselot C., Labat-Robert J. Modifications of the relative rates of biosynthesis of collagen and fibronectin in diabetes. Ann. NY Acad. Sci. 580:1990;576-578.
46. Labat-Robert J. Fibronectin in malignancy. Effect of age. Semin. Cancer Biol. 12:2002;187-195.
47. Labat-Robert J., Potazman J.P., Derouette J.C., Robert L. Age-dependent increase of human plasma fibronectin. Cell. Biol. Int. Rep. 5:1981;969-973.
48. Labat-Robert J., Fourtanier A., Boyer-Lafargue B., Robert L. Age-dependent increase of elastase type activity in mouse skin. Effect of UV-irradiation. J. Photochem. Photobiol. 57:2000a;113-118.
49. Labat-Robert J., Marques M.A., N'Doye S., Alperovitch A., Moulias R., Allard M., Robert L. Plasma fibronectin in french centenarians. Arch. Gerontol. Geriat. 31:2000b;95-105.
50. Lahmann C., Bergemann J., Harison G., Young A.R. Matrix metalloproteinase-1 and skin ageing in smokers. Lancet. 357:2001;935-936.
51. Lambert-Vidmar S., Lottspeich F., Emod I., Planchenault T., Keil-Dlouha V. Latent fibronectin-degrading serine protease activity in N-terminal heparin-binding domain of human plasma fibronectin. Eur. J. Biochem. 201:1991;71-77.
52. Langenbach K.J., Sottile J. Identification of protein-disulfide isomerase activity in fibronectin. J. Biol. Chem. 274:1999;7032-7038.
53. Lopez-Armada M.J., Gonzalez E., Gomez-Guerrero C., Egido J. The 80-kD fibronectin fragment increases the production of fibronectin and tumour necrosis factor-alpha (TNF-α) in cultured mesangial cells. Clin. Exp. Immunol. 107:1997;398-403.
54. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell. Biol. 13:2001;534-540.
55. Marchina E., DePetro G., Barlati S. Interaction of tissue plasminogen activator with fibronectin and fibronectin fragments. Fibrinolysis. 7:1993;51-57.
56. Millis A.J.T., Hoyle M., McCue H.M., Martini H. Differential expression of metallopoteinases and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp. Cell. Res. 201:1992;373-379.
57. Monnier V.M., Glomb M., Elgawish A., Sell D.R. The mechanism of collagen cross-linking in diabetes. A puzzle nearing resolution. Diabetes. 45:1996;567-572.
58. Morla A., Ruoslahti E. A fibronectin self-assembly site involved in fibronectin matrix assembly: reconstitution in a synthetic peptide. J. Cell. Biol. 118:1992;428-429.
59. Morla A., Zhang A.Z., Ruoslahti E. Superfibronectin is a functionally distinct form of fibronectin. Nature. 367:1994;193-196.
60. Moyano J.V., Carnemolla B., Dominguez-Jimenez C., Garcia-Gila M., Albar J.P., Danchez-Aparicio P., Leprini A., Querze G., Zardi L., Garcia-Pardo A. Fibronectin type III 5 repeat contains a novel cell adhesion sequence KLDAPT which binds activated alpha4 beta1 and alpha4beta7 integrins. J. Biol. Chem. 272:1997;24832-24836.
61. Murano S., Thweatt R., Shmookler R.J., Jones R.A., Moerman E.J., Goldstein S. Diverse gene sequences are overexpressed in Werner syndrome fibroblasts undergoing premature replicative senescence. Mol. Cell. Biol. 11:1991;3905-3914.
62. Ohashi T., Kiehart D.P., Erickson H.P. Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein. Proc. Natl. Acad. Sci. USA. 96:1999;2153-2158.
63. Péterszegi G., Robert A.M., Robert L. Presence of the elastin-laminin receptor on human activated lymphocytes. CR Acad. Sci. 319:1996;799-803.
64. Péterszegi G., Texier S., Robert L. Human helper and memory lymphocytes exhibit an inducible elastin-laminin receptor. Int. Arch. Allergy. Immunol. 114:1997;218-223.
65. Pierschbacher M.D., Hayman E.G., Ruoslahti E. Location of the cell attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Cell. 26:1981;259-267.
66. Pierschbacher M.D., Hayman E.G., Ruoslahti E. Synthetic peptide with cell attachment activity of fibronectin. Proc. Natl. Acad. Sci. USA. 80:1983;1224-1227.
67. Planchenault T., Lambert-Vidmar S., Imhoff J.M., Blondeau X., Emod I., Lottspeich F., Keil-Dlouha V. Potential proteolytic activity of human plasma fibronectin: fibronectin gelatinase. Biol. Chem. Hoppe-Seyler. 371:1990;117-128.
68. Puschel H.U., Chang J., Muller P.K., Brinckmann J. Attachment of intrinsically and extrinsically aged fibroblasts on collagen and fibronectin. J. Photochem. Photobiol. B. 27:1995;399-446.
69. Rasoamanantena P., Labat-Robert J., Goldstein S. Variations de la biosynthèse et quantification de l'ARNm de la fibronectine humaine au cours du vieillissement en culture. CR Soc. Biol. 187:1993;238-246.
70. Rasoamanantena P., Thweatt R., Labat-Robert J., Goldstein S. Altered regulation of fibronectin gene expression in Werner syndrome fibroblasts. Exp. Cell Res. 213:1994;121-127.
71. Reed M.J., Ferara N.S., Vernon R.B. Impaired migration, integrin function, and actin cytoskeletal organization in dermal fibroblasts from a subset of aged human donors. Mech. Ageing Dev. 122:2001;1203-1220.
72. Robert L. Aging of the vascular wall and atherogenesis. Role of the elastin-laminin receptor. Novartis Price Lecture. Gerontology. 44:1998;307-317.
73. Robert C., Lesty C., Robert A.M. Ageing of the skin: study of elastic fiber network. Modifications by computerized image analysis. Gerontology. 34:1988;851-858.
74. Robert L., Jacob M.P., Fülöp T., Timar J., Hornebeck W. Elastonectin and the elastin receptor. Pathol. Biol. 37:1989;736-741.
75. Shakibaei M., Abou-Rebyeh H., Merker H.J. Integrins in ageing cartilage tissue in vitro. Histol. Histopathol. 8:1993;715-723.
76. Sechler J.L., Rao H., Curniskey A.M., Vega-Colon L., Smith M.S., Murata T., Schwarzbauer J.E. A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly: reconstruction in a synthetic peptide. J. Cell Biol. 118:2001;2601-2609.
77. Schenk S., Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol. 13:2003;366-375.
78. Schwarzbauer J.E., Sechler J.L. Fibronectin fibrillogenesis: a paradigm for matrix assembly. Curr. Opin. Cell Biol. 11:1999;622-627.
79. Stanton H., Ung L., Fosang A.J. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. Biochem. J. 15:2002;181-190.
80. Sternlicht M.D., Werb Z. Hox matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:2003;463-516.
81. Tsilibari E.C., Charonis A.S., Reger L.A., Wohlhueter R.M., Furcht L.T. The effect of nonenzymatic glycation on the main non collagenous NC1 domain to type IV collagen. J. Biol. Chem. EMBO J. 1:1988;513-5116.
82. Ugarova T.P., Zamarron C., Veklich Y., Bowditch R.D., Ginsberg M.H., Weisl J.W., Plow E.F. Conformational transitions in the cell binding domain of fibronectin. Biochemistry. 34:1995;4457-4466.
83. Verzar, F., 1964. Aging of the collagen fiber. In: Hall, D.A. (Ed.), International Review on connective tissue research, vol. 2. Academic Press, New York, pp. 243-300.
84. Watanabe K., Takahashi H., Habu Y., Kamiya-Kubushiro N., Kamiya S., Nakamura H., Yajima H., Ishii T., Katayama T., Miyazaki K., Fukai F. Interactions with heparin and matrix metalloproteinase 2 cleavage expose a cryptic antiadhesive site of fibronectin. Biochemistry. 39:2000;7138-7144.
85. Werb Z., Tremble P.M., Behrendtsen O., Crowley E., Damsky D.H. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109:1989;877-889.
86. Wilson S.H., Ljubimov A.V., Morla A.O., Caballero S., Shaw L.C., Spoerri P.E., Tarnuzzer R.W., Grant M.B. Fibronectin fragments promote human retinal endothelial cell adhesion and proliferation and ERK activation through alpha5beta1 integrin and PI3-kinase. Invest. Ophthalmol. Vis. Sci. 44:2003;1704-1715.
87. Zhong C., Chrzanowska-Wodnicka M., Brown J., Belkin A.M., Burridge K. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 141:1998;539-551.